Lilly Direct Zepbound Pricing: How the $349 Vial Program Actually Works

Trust signals

> Reviewed by FormBlends Medical Team · Last updated May 2026 · 10 sources cited · As of May 2026 — confirm current pricing directly with the pharmacy or manufacturer.

Key Takeaways

• Lilly Direct sells Zepbound single-dose vials at approximately $349/month (2.5 mg), $499/month (5 mg and 7.5 mg), and higher tiers for 10, 12.5, and 15 mg
• The program is a manufacturer-direct cash-pay channel; insurance is not billed
• Each monthly order includes four single-dose vials, syringes, and needles
• Lilly Direct ships to all 50 states and Washington D.C. with free shipping
• For patients with strong insurance coverage of the pen, Lilly Direct vials may not be cheaper; for cash-pay patients, Lilly Direct is typically the cheapest brand-name path

Direct answer

Lilly Direct sells brand Zepbound in single-dose vial format at $349/month for 2.5 mg (titration only) and $499/month for 5 mg and 7.5 mg as of May 2026. Higher doses (10, 12.5, 15 mg) are priced per the current Lilly Direct posting. The program is a manufacturer-direct cash-pay channel operated by Eli Lilly through a third-party pharmacy. Patients order through LillyDirect.com after a prescription is written for the vial NDC. Confirm current pricing directly with the pharmacy or manufacturer.

Table of contents

1. What Lilly Direct actually is
2. The current vial pricing tiers
3. How to enroll and order
4. What ships in the box
5. The vial vs. pen tradeoff in detail
6. When Lilly Direct is cheaper than insurance, and when it is not
7. The technique question: vial-and-syringe administration
8. Lilly Direct vs. NovoCare and other manufacturer-direct programs
9. Limitations and what Lilly Direct does not offer
10. The decision framework
11. FAQ
12. Sources

What Lilly Direct actually is

Lilly Direct is Eli Lilly's manufacturer-operated direct-to-consumer pharmacy program, launched in early 2024 to expand access to its medications outside the traditional pharmacy-PBM-insurance channel. For Zepbound specifically, Lilly Direct opened in mid-2024 with single-dose vial dispensing at a meaningfully lower price than the autoinjector pen.

The operating structure:

• Eli Lilly sets the price and manages the catalog
• A contracted third-party pharmacy fulfills orders
• Patients order through the LillyDirect.com portal with a valid prescription
• Payment is made directly to Lilly Direct at the time of order; insurance is not billed
• Product ships directly to the patient's address with cold-chain packaging

Lilly Direct is a real, legitimate Eli Lilly program. The product shipped is the same FDA-approved Zepbound manufactured by Lilly. The vial format uses a different NDC than the pen but the active drug (tirzepatide) is identical.

The current vial pricing tiers

Dose	Monthly price	Annual cost	Note
2.5 mg	$349	~$4,188	Titration only; most patients are on this dose for ~4 weeks
5 mg	$499	~$5,988	Common starting maintenance dose
7.5 mg	$499	~$5,988	Intermediate dose
10 mg	Per current Lilly Direct posting	Varies	Common maintenance dose
12.5 mg	Per current Lilly Direct posting	Varies	Maintenance dose
15 mg	Per current Lilly Direct posting	Varies	Maximum dose

Lilly has adjusted pricing since launch as the program expanded. Patients should verify the current rate at the time of ordering. The lower doses (2.5 and 5 mg) have held more consistent pricing than the higher doses.

How to enroll and order

The Lilly Direct workflow:

1. Patient consults with a prescriber (in-person, telehealth, or through Lilly Direct's partnered telehealth platform)
2. Prescriber writes a Zepbound prescription specifying the vial NDC (not the pen NDC)
3. Prescription is sent to Lilly Direct or Lilly Direct's contracted pharmacy
4. Patient creates an account on LillyDirect.com, enters payment information, and confirms the order
5. Product ships from the contracted pharmacy with cold-chain packaging, typically arriving within 3 to 7 days
6. Monthly refills can be scheduled automatically

Some prescribers are familiar with the vial NDC and the Lilly Direct workflow; others may need a brief education on the difference. Lilly Direct provides prescriber resources to streamline this.

What ships in the box

A standard Lilly Direct Zepbound monthly order includes:

• Four single-dose vials (one weekly dose each)
• Syringes appropriate for the vial dose
• Needles
• Instructional materials covering injection technique
• Cold-chain packaging with ice packs to maintain temperature in transit

Not included: sharps container. Patients arrange their own sharps disposal through pharmacies, local disposal programs, or commercial sharps services.

The vial vs. pen tradeoff in detail

Factor	Pen (retail)	Vial (Lilly Direct)
Monthly cost	$1,059 cash; $25-$200 with insurance	$349-$499 cash-pay; insurance not billed
Format	Single-use prefilled autoinjector	Single-dose glass vial
Injection technique	Push button; minimal training	Draw into syringe; technique training needed
Dose flexibility	Fixed; one pen = one dose	Fixed; one vial = one dose
Travel-friendly	Yes; pen is compact and labeled	Moderate; vial, syringe, needle, alcohol swab all needed
Shelf life refrigerated	Per labeled expiration	Per labeled expiration
Visible needle	No (autoinjector hides it)	Yes (manual injection)

The pen wins on convenience. The vial wins on cost for cash-pay patients. For insured patients with low copays, the pen is the dominant choice. For uninsured or excluded patients, the vial is the dominant choice.

When Lilly Direct is cheaper than insurance, and when it is not

Lilly Direct is not always the cheapest option:

• Commercial insurance covers Zepbound at $25-$80 copay with savings card: stay on the pen via insurance; Lilly Direct vials are more expensive per month
• Commercial insurance covers Zepbound at $150-$300 copay or coinsurance: Lilly Direct vials may be similar or cheaper; run both numbers
• Commercial insurance excludes Zepbound entirely: Lilly Direct vials are typically cheaper than the savings card insurance-doesn't-cover tier on the pen
• Medicare with OSA indication coverage: depends on Part D copay; with the $2,000 annual cap, full-year exposure is bounded
• Uninsured: Lilly Direct is typically the cheapest brand-name option; Lilly Cares is $0 if approved

The technique question: vial-and-syringe administration

Vial-and-syringe administration is not difficult, but it requires comfort that the pen format eliminates. The steps:

1. Wash hands, gather supplies (vial, syringe, needle, alcohol swabs)
2. Inspect the vial for clarity
3. Wipe the vial stopper with alcohol
4. Draw air into the syringe equal to the dose volume, inject air into the vial
5. Invert the vial and draw the full dose
6. Check for air bubbles, adjust if needed
7. Wipe injection site, pinch skin, insert needle, push plunger slowly
8. Withdraw needle, dispose of sharps

Most patients learn this within one or two doses. Lilly Direct provides written and video instructional materials. Patients uncomfortable with needles or with manual dexterity issues may struggle and may prefer to pay pen pricing.

Lilly Direct vs. NovoCare and other manufacturer-direct programs

Program	Drug	Approximate monthly cost	Format
Lilly Direct	Zepbound (tirzepatide)	$349-$499+	Single-dose vial
NovoCare Pharmacy direct-pay	Wegovy (semaglutide)	~$499	Autoinjector pen
Lilly Direct (Mounjaro)	Mounjaro	Not available; pen only	N/A
NovoCare (Ozempic)	Ozempic	Not available as direct-pay	N/A

Lilly and Novo Nordisk have both created manufacturer-direct cash-pay channels for their obesity-indicated GLP-1s. Diabetes-indicated products (Mounjaro and Ozempic) do not currently have equivalent direct-pay programs.

Limitations and what Lilly Direct does not offer

• No insurance billing; cash payment only
• No discounts beyond posted price (no GoodRx or SingleCare stacking)
• No pen format through Lilly Direct (pens go through traditional pharmacies)
• No patient assistance for income-qualifying patients through this channel (Lilly Cares is separate)
• No combination with the Zepbound Savings Card
• Subject to manufacturer policy changes; current pricing is not guaranteed long-term

The decision framework

Use Lilly Direct vials if: you are uninsured, your insurance excludes Zepbound, your copay through insurance is higher than $499, or you prefer the lower price and are comfortable with vial administration.

Use the pen via insurance if: your copay is below $499 after the savings card, you have manual dexterity or vision issues making syringe administration difficult, or you have strong needle aversion that the pen format mitigates.

Use Lilly Cares if: you are uninsured with household income at or below 400% of FPL. Free Zepbound for qualifying patients.

Use compounded tirzepatide if: Lilly Direct's price is still out of reach and you accept the regulatory tradeoffs of compounded products. Typical pricing $299-$549 through 503A pharmacies.

FAQ

How much is Zepbound on Lilly Direct in 2026? Approximately $349/month for 2.5 mg, $499/month for 5 mg and 7.5 mg. Higher doses per the current posting.

Who is eligible for the Lilly Direct vial program? Any U.S. patient with a valid Zepbound vial prescription. Primarily designed for cash-pay patients.

Can I use insurance with Lilly Direct? No. Lilly Direct does not bill insurance; it operates as a cash-pay channel.

Does Lilly Direct ship Zepbound nationwide? Yes, to all 50 states and D.C., with free shipping.

What is included in a Lilly Direct Zepbound order? Four single-dose vials, syringes, needles, instruction materials, cold-chain packaging.

How is Lilly Direct different from a regular pharmacy fill? Lilly Direct dispenses the vial format manufacturer-direct at lower cash price. Regular pharmacies dispense the pen at retail pricing through insurance or cash.

Is Lilly Direct a real Eli Lilly program? Yes. Operated by Eli Lilly with a contracted third-party pharmacy.

Will Lilly Direct prices change? Lilly has adjusted pricing since launch. Verify current rates at order time.

Can I switch from pen to vial? Yes, with a new prescription written for the vial NDC. Discuss with your prescriber.

Does Lilly Direct require a Lilly Direct telehealth visit? No. Any licensed U.S. prescriber can write the vial prescription. Lilly Direct's partnered telehealth platform is one option among many.

What happens if I can no longer afford Lilly Direct? Apply for Lilly Cares if income-eligible. If not, consider compounded tirzepatide via a 503A pharmacy.

Sources

1. Eli Lilly and Company. Lilly Direct Zepbound program documentation. LillyDirect.com. 2026.
2. U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. 2024.
3. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022 (SURMOUNT-1).
4. Aronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity. JAMA. 2024 (SURMOUNT-4).
5. Malhotra A et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine. 2024 (SURMOUNT-OSA).
6. Lilly Cares Foundation. Patient assistance program documentation. 2026.
7. Centers for Medicare and Medicaid Services. Medicare Part D 2026 redesign and OOP cap. CMS.gov. 2026.
8. Novo Nordisk. NovoCare direct-pay program for Wegovy. NovoCare.com. 2026.
9. Kaiser Family Foundation. Manufacturer Direct-to-Consumer Drug Programs. 2025.
10. USP. Standards for Compounded Sterile Preparations (USP 797). 2023.

Footer disclaimers

Platform Disclaimer. FormBlends connects patients with independent licensed clinicians and partnered pharmacies. We are not a pharmacy and do not prescribe medication; we are not affiliated with Lilly Direct or Eli Lilly and Company. All clinical decisions are made by the treating provider.

Compounded Medication Notice. References to compounded tirzepatide describe products prepared by 503A state-licensed pharmacies under specific prescriptions. Compounded preparations are not FDA-approved and not interchangeable with brand Zepbound dispensed through Lilly Direct.

Results Disclaimer. Pricing data reflects Lilly Direct posted rates and related manufacturer information available in May 2026. Lilly Direct pricing has been adjusted since the program launched; verify current rates at the time of ordering before relying on figures here.

Trademark Notice. Zepbound, Mounjaro, Lilly Direct, and Lilly Cares are registered trademarks of Eli Lilly and Company. Wegovy, Ozempic, and NovoCare are registered trademarks of Novo Nordisk A/S. FormBlends has no affiliation with either manufacturer or with Lilly Direct's contracted pharmacy partners.